The 79 rating InvestorsObserver gives to Tarsus Pharmaceuticals Inc (TARS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 93 percent of stocks in the Biotechnology industry, TARS’s 79 overall rating means the stock scores better than 79 percent of all stocks.
TARS has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on TARS!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Tarsus Pharmaceuticals Inc Stock Today?
Tarsus Pharmaceuticals Inc (TARS) stock has gained 7.51% while the S&P 500 is lower by -1.24% as of 1:16 PM on Tuesday, Sep 20. TARS is up $1.17 from the previous closing price of $15.57 on volume of 48,073 shares. Over the past year the S&P 500 has fallen -11.62% while TARS is lower by -21.96%. TARS lost -$2.69 per share the over the last 12 months.
Click Here to get the full Stock Report for Tarsus Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
